Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b)

BACKGROUND: Immune-Oncology (IO) improves Overall Survival (OS) in metastatic Renal Cell Carcinoma (mRCC). The prognostic impact of previous Cytoreductive Nephrectomy (CN) and radical nephrectomy (RN), with curative intent, in patients treated with IO is not well defined. The aim of our paper is to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Stellato, Marco, Santini, Daniele, Verzoni, Elena, De Giorgi, Ugo, Pantano, Francesco, Casadei, Chiara, Fornarini, Giuseppe, Maruzzo, Marco, Sbrana, Andrea, Di Lorenzo, Giuseppe, Soraru, Mariella, Naglieri, Emanuele, Buti, Sebastiano, De Vivo, Rocco, Napolitano, Andrea, Vignani, Francesca, Mucciarini, Claudia, Grillone, Francesco, Roviello, Giandomenico, Di Napoli, Marilena, Procopio, Giuseppe
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8217989/
https://ncbi.nlm.nih.gov/pubmed/34168997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.682449
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados